March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
City of Hope Physicians and Researchers Announce Breakthroughs at AACR 2018
April 19, 2018 | Leticia Marquez
City of Hope scientists and doctors presented their latest cancer research at the annual meeting of the American Association for Cancer Research at Chicago’s McCormick Place on April 14 to 18.
CAR T Laboratory Research Yields Promising Prostate Cancer Results
April 17, 2018 | Letisia Marquez
City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.
Sound Therapy: TGen Tests Ultrasound to Enhance Cancer Drug Delivery
March 26, 2018 | City of Hope
City of Hope affiliate TGen has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.
Leukemia Drug Shows Promise Against Rare Ovarian Cancer
March 2, 2018 | City of Hope
City of Hope affiliate TGen has found that an anti-cancer drug used to fight leukemia shows promise against SCCOHT, a rare and aggressive type of ovarian cancer.
With New CAR T Approach, City of Hope CEACAM Research Comes Full Circle
February 9, 2018 | Jyoti Madhusoodanan
CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and CEACAMs, have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.
Inside the Lab: Preventing breast cancer from invading the brain
July 24, 2017 | Denise Heady
A study led by City of Hope neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., offers novel insights on how cancer cells in HER2-positive breast cancer develop the ability to break through the blood-brain barrier and, ultimately, how they can be stopped.